Norgine Limited is a leading European specialist pharmaceutical company established in 1926. Based at New Road, Hengoed, CF82 8SJ, Norgine operates as a limited company with a significant international presence. The company’s core business revolves around the development, manufacture, and commercialization of innovative pharmaceutical products. Norgine’s history spans over a century, marked by a commitment to scientific advancement and patient well-being. The company’s strategic focus is on creating impactful solutions that address unmet medical needs globally. Norgine specializes in a diverse range of therapeutic areas, consistently investing in research and development to introduce novel treatments. As a global business partner, Norgine leverages extensive partnerships to expand its reach and ensure product accessibility worldwide. The company’s international network facilitates market penetration and strengthens its position within the pharmaceutical landscape. Norgine’s operations are structured as a temporary worker service, reflecting its dedication to providing skilled personnel. Norgine’s SIC codes include: - 21100: Manufacture of basic pharmaceutical products. The company’s activities encompass a broad spectrum of pharmaceutical manufacturing, including active pharmaceutical ingredients (APIs) and finished dosage forms.

Norgine Limited is a leading European specialist pharmaceutical company established in 1926. Based at New Road, Hengoed, CF82 8SJ, Norgine operates as a limited company with a significant international presence. The company’s core business revolves around the development, manufacture, and commercialization of innovative pharmaceutical products. Norgine’s history spans over a century, marked by a commitment to scientific advancement and patient well-being. The company’s strategic focus is on creating impactful solutions that address unmet medical needs globally. Norgine specializes in a diverse range of therapeutic areas, consistently investing in research and development to introduce novel treatments. As a global business partner, Norgine leverages extensive partnerships to expand its reach and ensure product accessibility worldwide. The company’s international network facilitates market penetration and strengthens its position within the pharmaceutical landscape. Norgine’s operations are structured as a temporary worker service, reflecting its dedication to providing skilled personnel. Norgine’s SIC codes include: - 21100: Manufacture of basic pharmaceutical products. The company’s activities encompass a broad spectrum of pharmaceutical manufacturing, including active pharmaceutical ingredients (APIs) and finished dosage forms.